EC
FSTX

EcoR1 Capital’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

EcoR1 Capital’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-46,000
Closed -$395K – 82
2021
Q2 		$395K Hold
46,000
– – 0.01% 71
2021
Q1 		$498K Buy
+46,000
New +$447K 0.02% 68
2017
Q4 		– Sell
-4,000
Closed -$269K – 49
2017
Q3 		$269K Buy
+4,000
New +$229K 0.04% 39

Other funds holding FSTX

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital's FSTX Position: Q3 2021 in Review

EcoR1 Capital sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2021, closing a stake of 46,000 shares — an estimated $395K sold.

EcoR1 Capital first reported a position in FSTX in Q3 2017 and held it in 3 quarters. The position peaked at $498K in Q1 2021. 37 funds tracked by Wall St. Rank hold FSTX as of Q3 2021.

  • EcoR1 Capital reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • EcoR1 Capital sold 46,000 F-star Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $395K.
  • EcoR1 Capital first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2017 and held it in 3 quarters.
  • EcoR1 Capital's F-star Therapeutics, Inc. Common Stock position peaked at $498K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2021.

Based on EcoR1 Capital's 13F filing for Q3 2021, filed 15 Nov 2021.